UK DRI and NHS collaborate on digitally enabled dementia care platform
Around one in five dementia hospitalisations are due to potentially preventable causes
Read MoreAround one in five dementia hospitalisations are due to potentially preventable causes
Read MoreThe neurodegenerative condition currently affects more than 944,000 people in the UK
Read MoreMyricx Bio’s therapies include treatments for breast, lung and colorectal cancer
Read MoreThe serious, progressive kidney disease affects nearly 850 million people worldwide
Read MoreMore than 176,000 people in the UK are living with a stoma, according to NHS data
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
